T1	PROC 1 19	Evaluación del uso
#1	AnnotatorNotes T1	C0677392; Perform medication use evaluation; Health Care Activity
T2	CHEM 27 62	inhibidores de la bomba de protones
#2	AnnotatorNotes T2	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T3	CHEM 117 152	inhibidores de la bomba de protones
#3	AnnotatorNotes T3	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T4	CHEM 154 157	IBP
#4	AnnotatorNotes T4	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T5	CHEM 171 190	enzima H+/K+ ATPasa
#5	AnnotatorNotes T5	C0071766; H(+)-K(+)-Exchanging ATPase; Amino Acid, Peptide, or Protein · Enzyme
T6	ANAT 198 226	células parietales gástricas
#6	AnnotatorNotes T6	C0030559; Parietal Cells, Gastric; Cell
T7	CHEM 270 287	ácido clorhídrico
#7	AnnotatorNotes T7	C0020259; hydrochloric acid; Indicator, Reagent, or Diagnostic Aid · Inorganic Chemical
T8	DISO 372 410	enfermedad por reflujo gastroesofágico
#8	AnnotatorNotes T8	C0017168; Gastroesophageal reflux disease; Disease or Syndrome
T9	DISO 412 438	hemorragia digestiva aguda
#9	AnnotatorNotes T9	C0266809; Acute upper gastrointestinal hemorrhage; Pathologic Function
T10	DISO 440 447	úlceras
#10	AnnotatorNotes T10	C0041582; Ulcer; Pathologic Function
T13	DISO 489 498	dispepsia
#11	AnnotatorNotes T13	C0013395; Dyspepsia; Sign or Symptom
T14	DISO 500 511	gastropatía
#12	AnnotatorNotes T14	C0038354; Stomach Diseases; Disease or Syndrome
T15	CHEM 516 520	AINE
#13	AnnotatorNotes T15	C0003211; Anti-Inflammatory Agents, Non-Steroidal; Pharmacologic Substance
T16	PROC 522 532	profilaxis
#14	AnnotatorNotes T16	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T17	DISO 536 552	úlcera de estrés
#15	AnnotatorNotes T17	C2741638; Stress ulcer; Disease or Syndrome
T18	CHEM 644 647	IBP
#16	AnnotatorNotes T18	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T19	PROC 670 698	evaluación de su utilización
T20	PROC 779 841	estudio de corte transversal analítico con selección aleatoria
T21	CHEM 1022 1025	IBP
#17	AnnotatorNotes T21	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T22	DISO 1101 1113	enfermedades
#18	AnnotatorNotes T22	C0012634; Disease; Disease or Syndrome
T23	DISO 1149 1152	HTA
#19	AnnotatorNotes T23	C0020538; Hypertensive disease; Disease or Syndrome
T24	DISO 1154 1158	EPOC
#20	AnnotatorNotes T24	C0024117; Chronic Obstructive Airway Disease; Disease or Syndrome
T25	DISO 1161 1163	DM
#21	AnnotatorNotes T25	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T26	CHEM 1212 1215	IBP
#22	AnnotatorNotes T26	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T27	PROC 1226 1233	ingreso
#23	AnnotatorNotes T27	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T28	PROC 1286 1293	ingreso
#24	AnnotatorNotes T28	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T29	PROC 1294 1307	se prescribió
#25	AnnotatorNotes T29	C0033080; Prescription procedure; Health Care Activity | C2239117; Prescription of drug (procedure); Health Care Activity
T30	CHEM 1331 1334	IBP
#26	AnnotatorNotes T30	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T31	CHEM 1371 1374	IBP
#27	AnnotatorNotes T31	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T32	CHEM 1545 1548	IBP
#28	AnnotatorNotes T32	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T33	DISO 1616 1635	efectos secundarios
#29	AnnotatorNotes T33	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T34	DISO 1641 1673	interacciones con otros fármacos
#30	AnnotatorNotes T34	C0687133; Drug Interactions; Pathologic Function
T35	PROC 1688 1703	atención médica
#31	AnnotatorNotes T35	C0496675; Medical care; Health Care Activity
T36	ANAT 395 410	gastroesofágico
#32	AnnotatorNotes T36	C0744316; gastroesophageal; Body Location or Region
T37	CHEM 1665 1673	fármacos
#33	AnnotatorNotes T37	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T39	LIVB 556 575	pacientes de riesgo
#34	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group + C0242444; Population at Risk; Population Group
T40	LIVB 849 858	pacientes
#35	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	Duration 912 923	todo el año
T42	LIVB 976 985	pacientes
#36	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	Age 1048 1055	67 años
T44	LIVB 1087 1094	mujeres
#37	AnnotatorNotes T44	C0043210; Woman; Population Group
T45	LIVB 1194 1203	pacientes
#38	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T48	Neg_cue 1605 1611	evitar
T51	PHYS 257 287	secreción de ácido clorhídrico
#39	AnnotatorNotes T51	C0232552; Gastric acid secretion; Organ or Tissue Function
T52	ANAT 423 432	digestiva
#40	AnnotatorNotes T52	C0012240; Gastrointestinal system; Body System
T38	Date 924 928	2003
T47	Age 1063 1068	16-92
T49	PROC 1350 1354	alta
#41	AnnotatorNotes T49	C0030685; Patient Discharge; Health Care Activity | C0586003; Discharge from hospital; Health Care Activity
T11	DISO 457 488	gastritis o esofagitis erosiva,
#42	AnnotatorNotes T11	C3854048; Erosive gastritis; Disease or Syndrome | C0267055; Erosive esophagitis; Disease or Syndrome
A1	Assertion T33 Negated
A2	Assertion T34 Negated
T12	Neg_cue 1254 1256	no
T46	CONC 1263 1273	indicación
A3	Assertion T46 Negated
#43	AnnotatorNotes T46	C3146298; Indication; Idea or Concept
T50	CONC 1379 1389	indicación
A4	Assertion T50 Negated
#44	AnnotatorNotes T50	C3146298; Indication; Idea or Concept
T53	Quantifier_or_Qualifier 1390 1398	correcta
T54	Neg_cue 1375 1378	sin
R1	Negation Arg1:T54 Arg2:T50	
R2	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T53	
A5	Assertion T53 Negated
R3	Negation Arg1:T48 Arg2:T33	
R4	Negation Arg1:T48 Arg2:T34	
R5	Causes Arg1:T37 Arg2:T34	
R6	Negation Arg1:T12 Arg2:T46	
R7	Location_of Arg1:T6 Arg2:T51	
T55	Quantifier_or_Qualifier 297 302	basal
#45	AnnotatorNotes T55	C1442488; Baseline; Quantitative Concept
R8	Has_Quantifier_or_Qualifier Arg1:T51 Arg2:T55	
R9	Location_of Arg1:T36 Arg2:T8	
R10	Location_of Arg1:T52 Arg2:T9	
T56	Quantifier_or_Qualifier 448 455	activas
#46	AnnotatorNotes T56	C0679217; Active State; Idea or Concept
R11	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T56	
R12	Causes Arg1:T15 Arg2:T14	
R13	Before Arg1:T16 Arg2:T17	
R15	Experiences Arg1:T39 Arg2:T16	
R16	Experiences Arg1:T39 Arg2:T14	
R17	Experiences Arg1:T39 Arg2:T13	
R18	Experiences Arg1:T39 Arg2:T11	
R19	Experiences Arg1:T39 Arg2:T10	
R20	Experiences Arg1:T39 Arg2:T9	
R21	Experiences Arg1:T39 Arg2:T8	
R22	Overlap Arg1:T20 Arg2:T38	
R23	Has_Duration_or_Interval Arg1:T20 Arg2:T41	
T57	CONC 959 968	historias
#47	AnnotatorNotes T57	C0945958; Clinical notes and chart sections; Intellectual Product | C5204342; Clinical History; Intellectual Product
R24	Experiences Arg1:T42 Arg2:T21	
R25	Has_Age Arg1:T44 Arg2:T47	
R26	Has_Age Arg1:T44 Arg2:T43	
R27	Experiences Arg1:T44 Arg2:T22	
R28	Experiences Arg1:T44 Arg2:T23	
R29	Experiences Arg1:T44 Arg2:T24	
R30	Experiences Arg1:T44 Arg2:T25	
R31	Experiences Arg1:T45 Arg2:T26	
R32	Before Arg1:T26 Arg2:T27	
R33	Overlap Arg1:T28 Arg2:T29	
R34	Used_for Arg1:T30 Arg2:T29	
T58	Quantifier_or_Qualifier 1308 1327	de forma inadecuada
R35	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T58	
R36	Before Arg1:T29 Arg2:T49	
R37	Before Arg1:T28 Arg2:T49	
R38	Overlap Arg1:T49 Arg2:T31	
R40	Used_for Arg1:T31 Arg2:T29	
T59	Observation 1523 1537	uso incorrecto
#48	AnnotatorNotes T59	C0581388; Prescription Drug Misuse; Finding
R41	Used_for Arg1:T32 Arg2:T59	
R42	Before Arg1:T59 Arg2:T33	
R43	Before Arg1:T59 Arg2:T34	
T60	CONC 331 343	indicaciones
#49	AnnotatorNotes T60	C3146298; Indication; Idea or Concept
T61	CONC 624 636	indicaciones
#50	AnnotatorNotes T61	C3146298; Indication; Idea or Concept
T62	CONC 1504 1519	alta frecuencia
#51	AnnotatorNotes T62	C0205212; High frequency; Temporal Concept
#52	AnnotatorNotes T53	C2349182; Correct (qualifier); Qualitative Concept
R45	Negation Arg1:T54 Arg2:T53	
#53	AnnotatorNotes T58	C0205412; Inadequate (qualifier); Qualitative Concept
A6	Experiencer T39 Patient
A7	Experiencer T40 Patient
A8	Experiencer T42 Patient
A9	Experiencer T44 Patient
A10	Experiencer T45 Patient
